Illumina Inc (NAS:ILMN)
$ 140.6 -4.55 (-3.13%) Market Cap: 22.30 Bil Enterprise Value: 24.76 Bil PE Ratio: 0 PB Ratio: 10.45 GF Score: 79/100

Illumina Inc at Barclays Global Healthcare Conference Transcript

Mar 13, 2019 / 03:15PM GMT
Release Date Price: $299.64 (+0.98%)
Jack Meehan
Barclays Bank PLC, Research Division - VP & Senior Research Analyst

We're going to do our audience response questions. As we'll kick that off, please use the BlackBerry-type devices. First question, what do you view as Illumina's organic growth profile over the next 3 years?

(Voting)

Jack Meehan
Barclays Bank PLC, Research Division - VP & Senior Research Analyst

I think this might be an easy one here. We do ask the same question for every company. We have some naysayers but 2/3 in the double digits. Next question. How confident is your outlook for growth in China, which has been an important growth for Illumina?

(Voting)

Jack Meehan
Barclays Bank PLC, Research Division - VP & Senior Research Analyst

Kind of right down the middle split. And then finally, how would you like to see Sam deploying capital in 2019?

(Voting)

Jack Meehan
Barclays Bank PLC, Research Division - VP & Senior Research Analyst

Interesting.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot